Skip to content

Archer Aviation ACHR Common stock issuance for private placement

Common stock issuance for private placement at other companies

Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM
$259.95M
Archer Aviation logo
Archer AviationACHR
$0-100%
Navitas Semiconductor Corporation logo
Navitas Semiconductor CorporationNVTS
$25M
Beam Therapeutics logo
Beam TherapeuticsBEAM
$0
SoundHound AI, Inc. logo
SoundHound AI, Inc.SOUN
$0-100%
Cytokinetics logo
CytokineticsCYTK
$0-100%

Other financials

Income statement

See full
Revenue$1.6M
Gross profit$300.0K
Operating income-$254.6M-76.8%
Net income-$217.7M-133%
EPS (diluted)-$0.28-64.7%

Balance sheet

See full
Cash & equivalents$958.4M-7.6%
Total debt$121.8M+55.6%
Total equity$2.1B+106%
Total assets$2.3B+91.2%

Cash flow

See full
Operating cash flow-$149.1M-57.6%
CapEx$32.6M+226%
Free cash flow-$181.7M-73.7%

Valuation

See full
Market cap$4.01B+0.5%

Returns & leverage

See full
Return on equity-48%-12.4pp
Debt / equity0.1×0.0×
Current ratio18.1×+2.3×

Where this comes from

Reported directly by Archer Aviation in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfPrivatePlacement.

The official record: Archer Aviation’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Archer Aviation's common stock issuance for private placement.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Archer Aviation's common stock issuance for private placement?
Archer Aviation (ACHR) reported common stock issuance for private placement of $0 in Q1 2026.
How has Archer Aviation's common stock issuance for private placement changed year-over-year?
Archer Aviation's common stock issuance for private placement decreased by 100.0% year-over-year, from $10M to $0.
What does common stock issuance for private placement mean?
Represents the cash inflows generated from the sale of equity securities directly to private investors, such as institutional funds or strategic partners. This metric serves as a key indicator of the company's ability to raise capital outside of public market offerings.